14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KHTRF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Knight Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Knight Therapeutics Inc. is KHTRF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Knight Therapeutics Inc. Stock?
Knight Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Knight Therapeutics Inc. Stock?
Knight Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Knight Therapeutics Inc. Stock.

What's the current price of Knight Therapeutics Inc. Stock?
As of the end of day on the May 17, 2024, the price of an Knight Therapeutics Inc. (KHTRF) share was $4.39.

What is the 52-week high and low for Knight Therapeutics Inc. Stock?
The 52-week high for Knight Therapeutics Inc. Stock is $4.39 and the 52-week low is $3.20.

What is the market capitalization of Knight Therapeutics Inc. Stock?
As of the May 17, 2024, the market capitalization of Knight Therapeutics Inc. is 444.136M.

When is the next earnings date for Knight Therapeutics Inc.?
The upcoming earnings date for Knight Therapeutics Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Knight Therapeutics Inc.

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma... KHTRF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT